Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

Surveys and Questionnaires 53 Blood Specimen Collection 53 Specimen Handling 28 Radiotherapy 18 Observation 18 Interviews as Topic 13 Magnetic Resonance Spectroscopy 12 Surgical Procedures, Operative 10 Drug Therapy 10 Data Collection 10 Biopsy 10 Tomography, X-Ray Computed 9 darolutamide 8 Watchful Waiting 7 Standard of Care 7 ribociclib 6 palbociclib 6 Restraint, Physical 6 Patient Reported Outcome Measures 6 Magnetic Resonance Imaging 6 Immune Checkpoint Inhibitors 6 trastuzumab deruxtecan 5 Positron-Emission Tomography 5 Mass Screening 5 Genetic Testing 5 Esophagectomy 5 Breath Tests 5 Bevacizumab 5 enzalutamide 4 apalutamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × apixaban × 90 days × Clear all

NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡